Evidence map›Paper›PMID 26335302›Full record

ArticleJournal of endocrinological investigation2016

Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis.

F Marampon, G L Gravina, C Festuccia, V M Popov, A Colapietro, P Sanità, D Musio, F De Felice, A Lenzi, E A Jannini and 2 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Radiation-induced liver disease: beyond DNA damage.Cell cycle (Georgetown, Tex.) · 2023
    Review
  13. Vitamins and Radioprotective Effect: A Review.Antioxidants (Basel, Switzerland) · 2023
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

F MaramponDivision of Radiotherapy and Radiobiology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
G L GravinaDivision of Radiotherapy and Radiobiology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. giovanniluca.gravina@libero.it.
C FestucciaDivision of Radiotherapy and Radiobiology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
V M PopovDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
A ColapietroDivision of Radiotherapy and Radiobiology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
P SanitàDivision of Radiotherapy and Radiobiology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
D MusioDepartment of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy.
F De FeliceDepartment of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy.
A LenziDepartment Experimental Medicine, "Sapienza" University of Rome, Rome, Italy.
E A JanniniDepartment of System Medicine, University of Tor Vergata, 00133, Rome, Italy.
E Di CesareDivision of Radiotherapy and Radiobiology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
V TomboliniDepartment of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy.
University of L'Aquila · ITPoliclinico Umberto I · ITSapienza University of Rome · ITUniversity of Pennsylvania · USUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRadiotherapy toxicity is related to oxidative stress-mediated endothelial dysfunction. Here, we investigated on radioprotective properties of Vitamin D (Vit.D) on human endothelial cells (HUVEC).

methodsHUVEC, pre-treated with Vit.D, were exposed to ionizing radiation (IR): ROS production, cellular viability, apoptosis, senescence and western blot for protein detection were performed. The role of MAPKs pathway was investigated by using U0126 (10 μM) MEKs/ERKs-, SB203580 (2.5 μM) p38-inhibitor or by over/expressing MKK6 p38-upstream activator.

resultsVit.D reduced IR-induced ROS production protecting proliferating and quiescent HUVEC from cellular apoptosis or senescence, respectively, by regulating MAPKs pathways. In proliferating HUVEC, Vit.D prevented IR-induced apoptosis by activating ERKs while in quiescent HUVEC counteracted IR-induced senescence by inhibiting the p38-IR-induced activation. MEKs&ERKs inhibition in proliferating or MKK6/mediated p38 activation in quiescent HUVEC, respectively, reverted anti-apoptotic or anti-senescent Vit.D properties. SirT1 protein expression levels were up-regulated by Vit.D. ERKs inhibition blocked Vit.D-induced SirT1 protein up-regulation in proliferating cells. In quiescent HUVEC cells, p38 inhibition counteracted the IR-induced SirT1 protein down-regulation, while MKK6 transfection abrogated the Vit.D positive effects on SirT1 protein levels after irradiation. SirT1 inhibition by sirtinol blocked the Vit.D radioprotective effects.

conclusionVit.D protects HUVEC from IR induced/oxidative stress by positively regulating the MAPKs/SirT1 axis.

Indexed as

ApoptosisBlotting, WesternCell CycleCell ProliferationCells, CulturedCellular SenescenceEndothelium, VascularHumansHuman Umbilical Vein Endothelial CellsMitogen-Activated Protein Kinase 1Oxidative StressReactive Oxygen SpeciesSirtuin 1Vitamin DVitaminsMAPK1 protein, humanMitogen-Activated Protein Kinase 1Reactive Oxygen SpeciesSIRT1 protein, humanSirtuin 1Vitamin DVitaminsEndotheliumOxidative stressRadiotherapySirT1Vitamin D

Identifiers

PMID26335302
OpenAlexW1205960470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.